(CNEQ) The Alger Trust - Overview
Etf: Large-Cap Stocks, Growth, Equity, Non-Diversified
Dividends
| Dividend Yield | 0.53% |
| Yield on Cost 5y | 0.90% |
| Yield CAGR 5y | 339.02% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 30.0% |
| Relative Tail Risk | 6.00% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.79 |
| Alpha | 5.39 |
| Character TTM | |
|---|---|
| Beta | 1.361 |
| Beta Downside | 1.331 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.58% |
| CAGR/Max DD | 1.21 |
Description: CNEQ The Alger Trust December 22, 2025
The Alger ETF Trust (CNEQ) is a U.S.-based large-growth ETF that commits at least 80% of its net assets-and any investment-purpose borrowings-to equities of large-cap firms the manager deems to have strong growth prospects. By design, the fund concentrates its capital in a relatively small set of issuers, making it a non-diversified vehicle.
Key quantitative traits (as of the latest filing) include an expense ratio of 0.55%, total assets under management of roughly $150 million, and a top-10 holding concentration of about 45% of net assets. The portfolio is heavily weighted toward the technology and consumer discretionary sectors, which together account for roughly 55% of holdings, reflecting current macro drivers such as U.S. consumer spending growth and corporate cloud-computing adoption.
Investors should note that the fund’s performance is closely tied to the earnings-growth trajectory of its concentrated holdings and to broader U.S. GDP growth expectations, which the Federal Reserve projects at 2.0-2.5% annualized over the next two years.
For a deeper quantitative view, you might explore ValueRay’s analytics on CNEQ’s valuation multiples and earnings growth trends.
What is the price of CNEQ shares?
Over the past week, the price has changed by -0.41%, over one month by -3.81%, over three months by -4.34% and over the past year by +24.22%.
Is CNEQ a buy, sell or hold?
What are the forecasts/targets for the CNEQ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 39.1 | 15.6% |
CNEQ Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 244.2m USD (244.2m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 244.2m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 244.2m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 10.93% (E(244.2m)/V(244.2m) * Re(10.93%) + (debt-free company))
Discount Rate = 10.93% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)